Many thanks to Novartis Radiopharmaceuticals & the association of Neuroendocrine Tumors Network (NeT) for visiting the NET Cancer Center in Tübingen and raising awarness on a rare but dangerous disease.

The 🦁 Lion king 👑 Narrating Story of #Radiology and #Nuclear medicine 😂 ⁦@officialEANM⁩ ⁦prof. Stefano Fanti⁩ ⁦DAE India⁩ ⁦SNMMI⁩ ⁦JNM⁩

The calm before the storm 🌪️ The first participants have already checked in ✔️ Looking forward to a great start to our conference tomorrow! #CancerResearch #ifit2023 #zellamsee #science #conference

Last but not least! Our 3rd conference day just started and we are honored to listen to a keynote lecture of michal neeman kicking off our Functional and Molecular Multiparametric Imaging of Cancer I symposium #ifit2023 #conference #CancerResearch #imaging #zellamsee

Looking forward to hear great talks on day 3 of the IFIT conference in beautiful Zell am See.

Great research work with one of only three Biograph Vision Quadra PET/CT (Siemens Healthineers) devices in use in Germany so far led by our iFIT members Julia Mannheim & Prof. Dr. Christian la Fougère! #research #science #CancerResearch

🏆 Weltweit größter #Wissenschaftspreis für den Tübinger #Parkinson-Forscher, Prof. Dr. Thomas Gasser! Mehr Infos: medizin.uni-tuebingen.de/de/das-kliniku…

The new #season of #Sectio #chirurgica celebrates its premiere today! Prof. Dr. Adrien Daigeler and Dr. Sabrina Krauß from BG Klinik Tübingen open the first episode of the already 20th season with the title "The 1×1 of plastic and reconstructive surgery" 🕐6pm 💻sectio-chirurgica.de/livestream/

A game changer! Pluvicto's big splash gets an early preview: ow.ly/vW0X50PYHae #NuclearMedicine #ProstateCancer #RPTherapy

Check out our recent study on a new #CD19 immunoPET technique: pubmed.ncbi.nlm.nih.gov/38735945/. We present a way to non-invasively visualize CD19 expression in B-cell non-Hodgkin lymphoma. This could enhance therapy guidance by addressing variability in CD19 levels across #tumour sites.